2023 Q3 Form 10-Q Financial Statement

#000090725423000078 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $63.77M $63.71M
YoY Change 4.39% 5.67%
Cost Of Revenue $17.36M $16.45M
YoY Change 8.01% 11.17%
Gross Profit $46.41M $47.26M
YoY Change 3.09% 3.88%
Gross Profit Margin 72.77% 74.18%
Selling, General & Admin $5.180M $5.678M
YoY Change -6.75% 0.23%
% of Gross Profit 11.16% 12.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.10M $12.11M
YoY Change -0.81% -2.12%
% of Gross Profit 26.07% 25.63%
Operating Expenses $17.46M $17.86M
YoY Change -1.25% -1.13%
Operating Profit $28.95M $29.40M
YoY Change 5.9% 7.17%
Interest Expense $12.48M $12.36M
YoY Change 12.34% 18.17%
% of Operating Profit 43.12% 42.04%
Other Income/Expense, Net
YoY Change
Pretax Income $16.71M $17.19M
YoY Change 7.72% 1.13%
Income Tax
% Of Pretax Income
Net Earnings $12.82M $13.16M
YoY Change 7.27% 1.12%
Net Earnings / Revenue 20.1% 20.66%
Basic Earnings Per Share $0.42 $0.43
Diluted Earnings Per Share $0.42 $0.43
COMMON SHARES
Basic Shares Outstanding 23.94M shares 23.93M shares
Diluted Shares Outstanding 24.06M shares 24.04M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.600M $11.47M
YoY Change -35.87% 2.74%
Cash & Equivalents $6.586M $11.47M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $56.90M $51.95M
Other Receivables $0.00 $0.00
Total Short-Term Assets $63.50M $63.42M
YoY Change -7.93% -4.93%
LONG-TERM ASSETS
Property, Plant & Equipment $1.851B $1.807B
YoY Change 9.12% 7.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.10M $22.80M
YoY Change 3.96% 0.13%
Total Long-Term Assets $1.897B $1.843B
YoY Change 8.98% 7.43%
TOTAL ASSETS
Total Short-Term Assets $63.50M $63.42M
Total Long-Term Assets $1.897B $1.843B
Total Assets $1.961B $1.907B
YoY Change 8.34% 6.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $58.10M $51.31M
YoY Change 62.43% 33.62%
Accrued Expenses $2.700M $2.900M
YoY Change -20.59% -19.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.30M $76.68M
YoY Change 35.2% 19.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.343B $1.294B
YoY Change 12.49% 11.06%
Other Long-Term Liabilities $23.00M $21.84M
YoY Change -11.15% -4.02%
Total Long-Term Liabilities $1.366B $1.316B
YoY Change 11.98% 10.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.30M $76.68M
Total Long-Term Liabilities $1.366B $1.316B
Total Liabilities $1.450B $1.393B
YoY Change 13.1% 11.19%
SHAREHOLDERS EQUITY
Retained Earnings -$285.0M -$280.9M
YoY Change 6.17% 6.61%
Common Stock $241.0K $240.0K
YoY Change 0.42% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $393.7M $395.4M
YoY Change
Total Liabilities & Shareholders Equity $1.961B $1.907B
YoY Change 8.34% 6.97%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $12.82M $13.16M
YoY Change 7.27% 1.12%
Depreciation, Depletion And Amortization $12.10M $12.11M
YoY Change -0.81% -2.12%
Cash From Operating Activities $16.30M $32.59M
YoY Change -36.14% 23.12%
INVESTING ACTIVITIES
Capital Expenditures $47.90M $56.21M
YoY Change -246.96% -260.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$47.90M -$56.21M
YoY Change 46.96% 60.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 26.60M 23.28M
YoY Change 329.45% 213.45%
NET CHANGE
Cash From Operating Activities 16.30M 32.59M
Cash From Investing Activities -47.90M -56.21M
Cash From Financing Activities 26.60M 23.28M
Net Change In Cash -5.000M -339.0K
YoY Change 470.78% -70.42%
FREE CASH FLOW
Cash From Operating Activities $16.30M $32.59M
Capital Expenditures $47.90M $56.21M
Free Cash Flow -$31.60M -$23.62M
YoY Change -154.37% -138.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Costs And Expenses
CostsAndExpenses
91906000 usd
us-gaap Costs And Expenses
CostsAndExpenses
87949000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
17189000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16997000 usd
CY2023Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
4027000 usd
CY2022Q2 us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
3981000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
13162000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
13016000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2799000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10363000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
10217000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
20784000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
20784000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Profit Loss
ProfitLoss
34852000 usd
us-gaap Profit Loss
ProfitLoss
34488000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2401000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
387000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
35239000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34488000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8296000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8107000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26943000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26381000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5597000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5597000 usd
bfs Total Comprehensive Income Loss Available To Common Stockholders
TotalComprehensiveIncomeLossAvailableToCommonStockholders
21346000 usd
bfs Total Comprehensive Income Loss Available To Common Stockholders
TotalComprehensiveIncomeLossAvailableToCommonStockholders
20784000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
521802000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
13227 shares
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
543000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
699 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
290000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
-2014000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
19651000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515835000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
15588000 shares
CY2023Q2 us-gaap Profit Loss
ProfitLoss
17189000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Cash Flow Hedging Instruments
UnrealizedGainLossOnCashFlowHedgingInstruments
2401000 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
19679000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
514044000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530487000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
61861 shares
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
2949000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
8007 shares
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
594000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
17491000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
18917000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530459000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
2949000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
19618000 shares
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1397000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16997000 usd
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
19642000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
530031000 usd
us-gaap Profit Loss
ProfitLoss
34488000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24130000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24704000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1122000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
941000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
843000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
908000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-27000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
48000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-4401000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-3068000 usd
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
2486000 usd
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
903000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3315000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1013000 usd
bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
3875000 usd
bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
4654000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1333000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2437000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68692000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66484000 usd
us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
14109000 usd
us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
7014000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
85257000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
44900000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99366000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51914000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
15300000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
25614000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
53531000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
78000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
82000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
23000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8000000 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
28421000 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
421000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3388000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1087000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6981000 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
0 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
1322000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
28336000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
27208000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10972000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10576000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28868000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17997000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1806000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3427000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13279000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14594000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11473000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11167000 usd
us-gaap Interest Paid Net
InterestPaidNet
22676000 usd
us-gaap Interest Paid Net
InterestPaidNet
19689000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
26364000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
16220000 usd
CY2023Q2 bfs Minimum Percentage Of Taxable Income Distribution To Shareholders
MinimumPercentageOfTaxableIncomeDistributionToShareholders
0.90
bfs Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2023Q2 us-gaap Number Of Stores
NumberOfStores
33 store
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates and assumptions relate to collectability of operating lease receivables and impairment of real estate properties. Actual results could differ from those estimates.</span></div>
CY2023Q2 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
9400000 usd
CY2023Q2 bfs Accrued Rent Write Offs
AccruedRentWriteOffs
300000 usd
CY2023Q2 bfs Accrued Rent Amount Accrued Not Yet Due
AccruedRentAmountAccruedNotYetDue
600000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements to conform to the presentation used as of and for the six months ended June 30, 2023.</span></div>
CY2023Q2 us-gaap Development In Process
DevelopmentInProcess
410966000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
319683000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2800000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2900000 usd
CY2023Q2 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
22800000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
22400000 usd
CY2023Q2 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
52700000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
51300000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22600000 usd
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
7100000 usd
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
7400000 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q2 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
8800000 shares
CY2022Q3 bfs Number Of Interest Rate Swaps
NumberOfInterestRateSwaps
2 swap
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1310000000 usd
CY2023Q2 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1090000000.00 usd
CY2023Q2 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
219000000 usd
CY2023Q2 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1330000000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1240000000 usd
CY2022Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1070000000.00 usd
CY2022Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
164000000 usd
CY2022Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1040000000.00 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsRemainderOfFiscalYear
16728000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year One
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearOne
83973000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearTwo
271086000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearThree
162468000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFour
123792000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFive
41863000 usd
CY2023Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsAfterYearFive
611879000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1311789000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17659000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1294130000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
17700000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
15800000 usd
CY2023Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
9100000 usd
CY2022Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
7900000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
16267000 usd
CY2022Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
12468000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
31780000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
24781000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
564000 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
465000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1122000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
941000 usd
CY2023Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4472000 usd
CY2022Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2474000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
8614000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4661000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
12359000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
10459000 usd
us-gaap Interest Expense
InterestExpense
24288000 usd
us-gaap Interest Expense
InterestExpense
21061000 usd
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
81000 usd
CY2022Q2 us-gaap Interest Income Operating
InterestIncomeOperating
2000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
189000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
2000 usd
CY2023Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12278000 usd
CY2022Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
10457000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24099000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
21059000 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
8200000 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
8100000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24043000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23963000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24034000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23924000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
16000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
15000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24044000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23979000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24035000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23939000 shares
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
231400 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
227800 usd
bfs Deferred Compensation Arrangement With Individual Contributions By Plan Participants Percentage Of Salary Maximum
DeferredCompensationArrangementWithIndividualContributionsByPlanParticipantsPercentageOfSalaryMaximum
0.02
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
132400 usd
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
111600 usd
bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3000000 usd
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3000000 usd
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
5028 shares
CY2023Q2 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
118987 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2800000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1768375 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.28
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
253500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.79
bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
770640 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
96875 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
49.24
bfs Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1925000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.08
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
770640 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1247375 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
52.28
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
91200 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
237724 usd
CY2023Q2 us-gaap Share Price
SharePrice
36.83
CY2023Q2 bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants Since Inception
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsSinceInception
1700000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2023Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
926300000 usd
CY2022Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
919200000 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
1090000000.00 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
1070000000.00 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
2919000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
1302000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-518000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-915000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
0 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 us-gaap Revenues
Revenues
63709000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16450000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
47259000 usd
CY2023Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12278000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12114000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5678000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
17189000 usd
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
56210000 usd
CY2023Q2 us-gaap Assets
Assets
1906694000 usd
CY2022Q2 us-gaap Revenues
Revenues
60293000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14797000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
45496000 usd
CY2022Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
10457000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12377000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5665000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16997000 usd
CY2022Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
35046000 usd
CY2022Q2 us-gaap Assets
Assets
1782486000 usd
us-gaap Revenues
Revenues
126758000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32731000 usd
us-gaap Gross Profit
GrossProfit
94027000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24099000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24130000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10946000 usd
us-gaap Profit Loss
ProfitLoss
34852000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
99366000 usd
CY2023Q2 us-gaap Assets
Assets
1906694000 usd
us-gaap Revenues
Revenues
122437000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31753000 usd
us-gaap Gross Profit
GrossProfit
90684000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
21059000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24704000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10433000 usd
us-gaap Profit Loss
ProfitLoss
34488000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
51914000 usd
CY2022Q2 us-gaap Assets
Assets
1782486000 usd

Files In Submission

Name View Source Status
0000907254-23-000078-index-headers.html Edgar Link pending
0000907254-23-000078-index.html Edgar Link pending
0000907254-23-000078.txt Edgar Link pending
0000907254-23-000078-xbrl.zip Edgar Link pending
bfs-06302023xex31.htm Edgar Link pending
bfs-06302023xex32.htm Edgar Link pending
bfs-06302023xex99a.htm Edgar Link pending
bfs-20230630.htm Edgar Link pending
bfs-20230630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
bfs-20230630_cal.xml Edgar Link unprocessable
bfs-20230630_def.xml Edgar Link unprocessable
bfs-20230630_lab.xml Edgar Link unprocessable
bfs-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfs-20230630_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending